The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Marks the World Head & Neck Cancer Day at the OCTF Conference
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
